Perceptions of Patients with Primary Nonadherence to Statin Medications
| Autor: | Derjung M. Tarn, Jon A. Turner, Alicia Fernandez, Keith Cox, Maureen Barrientos, Mark J. Pletcher, Janice B. Schwartz |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
Adult
medicine.medical_specialty Statin medicine.drug_class media_common.quotation_subject Hypercholesterolemia Hyperlipidemias Disease 030204 cardiovascular system & hematology Cardiovascular Article Medication Adherence 03 medical and health sciences 0302 clinical medicine 7.1 Individual care needs Clinical Research General & Internal Medicine Perception medicine Humans cardiovascular diseases 030212 general & internal medicine Adverse effect Qualitative Research media_common Pharmaceutical industry business.industry Prevention Statins Public Health Environmental and Occupational Health Evaluation of treatments and therapeutic interventions nutritional and metabolic diseases Focus Groups Health Services Focus group Heart Disease Good Health and Well Being Cardiovascular Diseases 6.1 Pharmaceuticals Family medicine Public Health and Health Services lipids (amino acids peptides and proteins) Management of diseases and conditions Hydroxymethylglutaryl-CoA Reductase Inhibitors Worry Family Practice business Qualitative research |
| Zdroj: | J Am Board Fam Med Journal of the American Board of Family Medicine : JABFM, vol 34, iss 1 |
| ISSN: | 1558-7118 1557-2625 |
| Popis: | Background: Despite emphasis on efforts to prevent cardiovascular disease (CVD), 13% to 34% of people never fill a prescribed statin (primary nonadherence). This study determined perceptions of adults with primary nonadherence to statins. Methods: Ten focus groups were conducted with 61 adults reporting primary nonadherence to statins (93% without known CVD). Participants were recruited from an academic medical center and nationwide Internet advertisements. Results: Major themes related to primary nonadherence were 1) desire to pursue alternatives before starting a statin (eg, diet and/or exercise, dietary supplements), 2) worry about risks and adverse effects of statins, 3) perceptions of good personal health (suggesting that a statin was not needed), and 4) doubt about the benefits of statins in the absence of disease. Additional themes included mistrust of the pharmaceutical industry, mistrust of prescribing providers, inadequate provider communication about statins, and negative prior experiences with medication. Although rare, a few patients said that high cholesterol does not require treatment if it is genetic. One third noted during focus group discussions that they did not communicate their decision not to take a statin to providers. Conclusions: Adults with primary nonadherence to statins describe seeking alternatives, avoiding perceived risks of statins, poor acceptance/understanding of CVD risk estimates, and doubts about the benefits of statins. Many do not disclose their decisions to providers, thus highlighting the need for provider awareness of the potential for primary nonadherence at the point of prescribing, and the need for future work to develop strategies to identify patients with potential primary nonadherence. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|